A recent tumor study in mice found that LAIR‐2‐Fc recombinant protein inhibits the binding of LAIR‐1 and collagen by blocking the PD‐1/PD‐L1 checkpoint, so as to achieve an anti‐tumor effect.50 Here, PDCD1 is linked to neoplasm.